Cvs Health (CVS) Receivables - Other (2017 - 2026)

Cvs Health (CVS) has reported Receivables - Other for 10 consecutive years, with $13.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Other rose 24.08% year-over-year to $13.0 billion; the trailing twelve-month figure through Jun 2026 stood at $13.0 billion (up 24.08% YoY), and the FY2025 full-year result was $10.6 billion, up 6.9% from the prior year.
• Receivables - Other rose to $13.0 billion in Q2 2026 per CVS's latest filing, from $12.5 billion in the prior quarter.
• Across five years, Receivables - Other topped out at $13.0 billion in Q2 2026 and bottomed at $8.0 billion in Q3 2022.
• Historically, Receivables - Other has averaged $10.3 billion across 5 years, with a median of $10.2 billion in 2023.
• The sharpest annual moves came in 2023 and 2024: Receivables - Other soared 32.56% in 2023, then dropped 17.02% in 2024.
• Over 5 years, Receivables - Other stood at $9.0 billion in 2022, then jumped by 32.56% to $11.9 billion in 2023, then decreased by 17.02% to $9.9 billion in 2024, then increased by 6.9% to $10.6 billion in 2025, then climbed by 22.93% to $13.0 billion in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $13.0 billion, $12.5 billion, and $10.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.